Last reviewed · How we verify

IV Furosemide

Rambam Health Care Campus · FDA-approved active Small molecule Quality 5/100

IV Furosemide is a Small molecule drug developed by Rambam Health Care Campus. It is currently FDA-approved.

At a glance

Generic nameIV Furosemide
SponsorRambam Health Care Campus
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about IV Furosemide

What is IV Furosemide?

IV Furosemide is a Small molecule drug developed by Rambam Health Care Campus.

Who makes IV Furosemide?

IV Furosemide is developed and marketed by Rambam Health Care Campus (see full Rambam Health Care Campus pipeline at /company/rambam-health-care-campus).

What development phase is IV Furosemide in?

IV Furosemide is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing